logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
22/12/2025
AstraZeneca: Enhertu approved for breakthrough therapy designation for early breast cancer treatment after neoadjuvant therapy.
Latest
2 m ago
China Merchants Shipping (601872.SH): Methanol dual-fuel powered VLCC oil tanker new ship delivery.
2 m ago
Notice on the reduction or exemption of delivery fees and related expenses issued by Energy Department in the previous period.
2 m ago
Rongda Corporation: Shareholders with more than 5% of the shares intend to transfer 5% of the shares by agreement.
2 m ago
ST Hua Yang: Provided a counter-guarantee of 100 million yuan to the controlling shareholder, with a total accumulated guarantee of more than 26 billion yuan.
2 m ago
Huazheng New Materials: Provided a guarantee of 175 million RMB to its subsidiary, with a total guarantee amount of 3.798 billion RMB.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.